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OBJECTIVES This study was designed to assess the prevalence and clinical significance of exaggerated
nonculprit lesion stenosis in the setting of acute (12 h) myocardial infarction (AMI).
BACKGROUND Although microvascular spasm may reduce nonculprit artery flow during AMI, it is unknown
whether increased tone may exaggerate nonculprit lesion severity.
METHODS In patients with additional angiography within nine months of AMI, and significant
nonculprit lesions imaged in matching views, stenosis severity was compared between studies
in a random blinded fashion using validated quantitative coronary angiography software.
Baseline demographics, medications, hemodynamics at each study, and clinical status at
follow-up (infarct/unstable angina/stable angina) were used to determine the independent
influence of the infarct presentation on stenosis exaggeration.
RESULTS From 548 patients with AMI (1/99 to 6/01, 321 with multivessel disease), 112 had additional
angiography; of these 48 had 59 lesions suitable for analysis. Between infarct and noninfarct
angiograms there was a significant change in minimal lumen diameter (1.53  0.51 mm vs.
1.78  0.65 mm, p  0.001) and percentage stenosis (49.3  14.5% vs. 40.4  16.6%, p 
0.0001) of the nonculprit lesion without significant change in reference segment diameter,
which was not predicted by changes in medication or hemodynamics. Twenty-one percent of
patients had lesions 50% at AMI that were 50% at non-AMI angiography. Infarct versus
noninfarct setting was the only significant independent predictor of change in nonculprit
stenosis.
CONCLUSIONS Significant exaggeration of nonculprit lesion stenosis severity occurs at infarct angiography,
which may affect revascularization decision making in an appreciable number of
patients. (J Am Coll Cardiol 2002;40:911–6) © 2002 by the American College of
Cardiology Foundation
Percutaneous coronary intervention (PCI) has evolved sub-
stantially over the past quarter century since Andreas
Gruntzig’s first report of coronary angioplasty (1). Complete
revascularization of multivessel disease with PCI is not only
feasible, but is associated with less morbidity and similar
mortality to bypass surgery even in high-risk patients (2).
Improved stent technology and antiplatelet therapy has
made it safer such that multivessel PCI in stable patients is
commonly being achieved with only one procedure and
excellent results (3).
The growing availability of coronary angiographic facili-
ties has meant that PCI is increasingly being used for
reperfusion in acute myocardial infarction (AMI), either as
the primary modality or as a backup if thrombolysis fails.
Around 30% to 60% of patients presenting with AMI have
multivessel disease (4–6), and management of nonculprit
lesions is controversial (that is, immediate PCI, deferred
PCI, or deferred coronary artery bypass grafting [CABG]).
The most common approach is to defer nonculprit revas-
cularization away from the unfavorable hemodynamic and
metabolic milieu of acute infarction, although in the setting
of cardiogenic shock, there appears to be a consensus that
ischemia should be relieved not only in the infarct-related
artery (IRA) but also in the non-IRA territories (7). Recent
evidence suggests that complete revascularization at the
time of infarction may be advantageous, even in the absence
of cardiogenic shock. First, slow flow in the non-IRA
territories is worse with 50% epicardial stenosis, is pro-
portional to percent of stenosis in this range (8), and is
associated with reduced non-IRA territory wall thickening,
which rapidly improves when flow is returned to normal (9).
Second, coronary plaque instability is frequently a multifocal
process: multiple complex plaques are often seen at infarct
PCI (10) and are associated with a significantly increased
risk of recurrent acute coronary syndromes that might be
prevented by multivessel PCI (11). Last, simultaneous
multivessel PCI at the time of infarction should limit
vascular access and anticoagulant-related bleeding compli-
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cations arising from further procedures, as well as reducing
costs.
To further complicate the conundrum, it has been our
clinical impression that nonculprit lesion severity was often
exaggerated at the time of infarction, and that this may have
significant effect on clinical decision making regarding
further revascularization. Although there is extensive liter-
ature on increased microvascular tone at the time of AMI,
change in macrovascular tone has never been recognized as
a significant source of nonculprit lesion severity exaggera-
tion. We performed a retrospective analysis of all patients
who had coronary angiography at the time of AMI, and
another coronary angiogram within nine months, to exam-
ine the extent and clinical significance of variation in the
severity of lesions in the nonculprit artery.
METHODS
We examined our infarct PCI database for all patients who
had coronary angiography at the time of confirmed infarc-
tion (within 12 h of pain with a view to primary or rescue
coronary angioplasty) between January 1999 and June 2001
and had a second coronary angiogram within nine months
(before January 1999 images were recorded on video,
preventing analysis using digital quantitative coronary an-
giography [QCA]). Myocardial infarction was confirmed in
each patient by a greater than threefold rise in serum
creatine kinase-myocardial band or a troponin T elevation
above 0.1 ng/ml. Telephone follow-up (95% complete) was
used to find all patients who had had another coronary
angiogram at another institution. All infarct angiograms
were then reviewed by two experienced operators to find
those patients who had a lesion in the nonculprit artery of
agreed severity 50% (by visual estimation). The culprit
was identified as the site of acute occlusion or impaired (
TIMI [Thrombolysis In Myocardial Infarction] 3) flow. If
there was normal flow in all vessels, a site with complex
plaque was inferred as the culprit by an associated wall
motion defect on left ventriculogram. Nonculprit lesions
were defined as lesions in an artery other than the infarct-
related artery with smooth angiographic borders and no
associated thrombus. We then assessed the additional an-
giograms to ensure that images were obtained in matching
projections (they were excluded for 5° difference in any
plane). Patients were excluded if nonculprit lesions were
revascularized before the second angiogram either by PCI
(multivessel PCI at the time of infarction was only per-
formed in patients with cardiogenic shock or multiple
culprit lesions) or CABG. End-diastolic images in the least
foreshortened view were used to measure lesion severity
using the QCA-CMS system (Medis, Leiden, The Neth-
erlands), as previously described (12). First angiographic
images from both studies were used (before any intracoro-
nary nitrates were administered). Analysis was performed by
two experienced operators who were blinded to the se-
quence of the angiograms. Patient characteristics recorded
included age, gender, Killip class on presentation, medica-
tions, atherosclerotic risk factors (smoking history, hyper-
tension, hyperlipidemia, diabetes mellitus, and family his-
tory of premature vascular disease), history of coronary
artery disease (past angina, AMI, PCI, or CABG), hemo-
dynamics (blood pressure and heart rate at the start of each
procedure), and clinical setting of the second angiogram
(stable vs. unstable coronary syndrome).
Comparisons of hemodynamic and angiographic data
between the two studies were made using paired t tests.
Multiple logistic regression was used to adjust for the effects
of baseline demographics, changes in medications, changes
in hemodynamics, and clinical setting on changes in non-
culprit vessel reference diameter and lesion severity. Con-
tinuous variables were compared between patient groups
using Student t test. Mann-Whitney rank-sum test was
used when the data did not fit a normal distribution.
Categorical variables were compared between patient groups
using chi-square or Fisher exact test where appropriate.
RESULTS
Between January 1999 and June 2001, 548 patients had
coronary angiography at time of AMI: 304 for primary PCI
(PP, presented with MI to our hospital) and 244 for rescue
PCI (RP, presented to a hospital without angiographic
facilities and either failed to reperfuse with thrombolysis or
were thrombolysis-ineligible). There were 321 patients with
operator-reported multivessel disease (176 [58%] from the
PP group, 145 [59%] from the RP group). A total of 112
patients (84 PP, 28 RP) had additional coronary angiogra-
phy within nine months: 14 for assessment of restenosis
(asymptomatic), 19 before planned PCI of a nonculprit
lesion, 17 before planned CABG, three before noncardiac
surgery, and 62 for assessment of recurrent chest pain or
anginal equivalent. Of these, 64 had either no significant
lesion in a nonculprit vessel (n  41), had coronary artery
grafting of the nonculprit lesion (n  5), or a matching
angiographic view was not available (n  18). This left 48
patients with 59 nonculprit lesions, and this constitutes our
study group.
Patient demographics are shown in Table 1 from the total
group, PP, multivessel disease, and the study group. At time
of AMI, 45 patients (94%) underwent PCI of the culprit
lesion, two (4%) were managed medically and one (2%) had
Abbreviations and Acronyms
AMI  acute myocardial infarction
CABG  coronary artery bypass grafting
IRA  infarct related artery
MLD  minimal luminal diameter
PCI  percutaneous coronary intervention
PP  primary PCI
QCA  quantitative coronary angiography
RCA  right coronary artery
RP  rescue PCI
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CABG. A median of 73 days (interquartile range 13 to 135
days) elapsed between angiograms. The additional angio-
gram was for stable symptoms in 37 patients (77%) and
unstable symptoms in 11 patients (23%): 17 were before
PCI, seven before CABG, four for restenosis, one before
noncardiac surgery, and 19 for assessment of chest pain. No
patient was on vasopressor agents at MI or follow-up.
Between infarct and noninfarct angiograms there was a
significant change in minimal lumen diameter (MLD) (1.53
 0.51 mm vs. 1.78 0.65 mm, p 0.001) and percentage
stenosis (49.3%  14.5% vs. 40.4%  16.6%, p  0.0001)
of the nonculprit lesion. The nonculprit vessel reference
diameter was not significantly different between study dates
(3.1  0.8 mm vs. 3.0  0.8 mm, p  0.3).
The differences in hemodynamics and medications be-
tween study dates are shown in Tables 2 and 3 respectively.
The groups were then divided into right coronary artery
(RCA) IRA or non-RCA IRA (Table 2). Diastolic blood
pressure was significantly higher in the non-RCA IRA
group, and there was a trend towards higher systolic blood
pressure and heart rate in the non-RCA IRA group at time
of the infarct angiogram compared to the RCA IRA group
and the noninfarct angiogram. There was no association on
multiple logistic regression between the difference in hemo-
dynamics or medication and the change in nonculprit lesion
MLD or percentage stenosis (all p  0.30).
Ten lesions (17%) in ten patients (21%) had nonculprit
lesions of 50% stenosis at time of AMI that were  50%
stenosis at time of non-AMI angiogram. In this group there
was a marked improvement in MLD (1.15  0.35 mm vs.
1.70 0.68 mm, p 0.05) and percentage stenosis (60.2
9.2 vs. 39.0  6.6, p  0.001), but no significant change in
reference diameter (3.0  0.8 vs. 2.8  1.0). If infarct
angiography were used to determine revascularization strat-
egy in these patients, they would be unnecessarily subject to
the risks of that strategy, be that PCI or CABG. This group
could not be predicted on the basis of infarct heart rate (71.2
 12.7 vs. 74.2  15.1, p  0.58), systolic blood pressure
(129.5  28.2 vs. 124.3  22.3, p  0.61), or Killip class
1/2/3 (41/5/2 vs. 10/0/0 p  0.41).
DISCUSSION
This study shows that severity of stenosis in moderately
obstructive nonculprit lesions is frequently exaggerated at
the time of myocardial infarction. These observations have
Table 1. Patient Demographics
Characteristic
Total Group
(n  548)
Primary Angioplasty
Group (n  304)
Multivessel Disease
Group (n  321)
Study Group
(n  48)
Age (yrs) 64 63 67.9 60.5
Women 153 (28%) 91 (30%) 87 (27%) 7 (15%)
Risk factors
Diabetes 93 (17%) 52 (17%) 67 (21%) 13 (27%)
Hypertension 247 (45%) 139 (46%) 167 (52%) 20 (42%)
Hypercholesterolemia 290 (53%) 163 (54%) 170 (53%) 33 (69%)
Current smoker 132 (24%) 79 (26%) 67 (21%) 6 (13%)
Previous smoker 153 (28%) 85 (28%) 100 (31%) 12 (25%)
History of
Previous angina 93 (17%) 50 (16%) 80 (25%) 14 (29%)
Previous myocardial infarct 93 (17%) 50 (16%) 77 (24%) 9 (19%)
Previous PCI 27 (5%) 15 (5%) 16 (5%) 6 (13%)
Previous CABG 44 (8%) 25 (8%) 45 (14%) 3 (6%)
Killip class 2 110 (20%) 57 (19%) 87 (27%) 8 (17%)
Left anterior descending 208 (38%) 119 (39%) 91 (28%) 26 (54%)
Left circumflex 86 (16%) 46 (15%) 61 (19%) 7 (15%)
Right coronary artery 158 (29%) 93 (31%) 99 (31%) 14 (29%)
Saphenous vein graft 18 (3%) 10 (3%) 16 (5%) 1 (2%)
Left main coronary artery 8 (1%) 4 (1%) 3 (1%) 0 (0%)
Not identified 71 (13%) 32 (11%) 51 (16%) 0 (0%)
Revascularization (in hospital)*
CABG 67 (12%) 41 (13%) 55 (17%) 0 (0%)
Stent 343 (62%) 200 (66%) 180 (56%) 43 (90%)
PTCA 70 (13%) 32 (11%) 51 (16%) 3 (6%)
Medical 72 (13%) 31 (10%) 35 (11%) 2 (4%)
Nonculprit artery
Left anterior descending 14 (24%)
Left circumflex 17 (29%)
Right coronary artery 28 (47%)
*Most major revascularization while in hospital (CABG  stent  PTCA  medical. If culprit stent/PTCA followed by
CABG, CABG scored).
CABG  coronary artery bypass graft; PCI  percutaneous coronary intervention; PTCA  percutaneous transluminal
coronary angioplasty.
913JACC Vol. 40, No. 5, 2002 Hanratty et al.
September 4, 2002:911–6 Nonculprit Exaggeration in AMI
important implications for decision making on complete
revascularization strategy in patients with multivessel dis-
ease. Potential causes for the dynamic component of non-
culprit stenosis include vasoconstriction, thrombus, plaque
regression at follow-up, or changes in reference segment
vessel tone, although vasoconstriction would appear the
most likely. In light of these findings, immediate PCI of
nonculprit lesions may expose the patient to unnecessary
risks of both acute complications and restenosis. If deferred
nonculprit revascularization is the chosen strategy, repeat
angiography may help prevent unnecessary procedures in
these patients.
This study is the first to systematically assess the severity
and clinical importance of nonculprit lesion exaggeration
during myocardial infarction. A previous case report of
significant vasospasm of a nonculprit lesion at the time of
myocardial infarction (13) might easily have originated from
a patient in whom myocardial infarction resulted from
extreme vasospasm rather than plaque rupture and throm-
bosis, making its general applicability unknown. This study
shows that exaggeration of nonculprit lesions is common
and, if immediate revascularization were to be attempted on
all lesions of 50% stenosis, would prompt unnecessary
PCI in one in five patients with multivessel disease.
Potential sources of nonculprit lesion exaggeration. The
reasons why nonculprit lesions become less stenotic at
follow-up include vasoconstriction of the lesion, relative
vasodilation of the angiographically normal reference seg-
ment or thrombus at the lesion site during AMI, regression
of nonculprit lesions with lipid-lowering therapy, and
change in medication and hemodynamics, although vaso-
constriction at the time of infarction would seem the most
likely. It is unlikely that our findings could be explained by
relative vasodilation of the reference segment during AMI,
as the reference segment diameters were similar between
study dates. Changes in medication between the study dates
had no effect on stenosis severity by univariate or multivar-
iate analysis. Although angiotensin-converting enzyme in-
hibitor and statin therapy became more frequent, intrave-
nous nitrate therapy was less frequent at follow-up, and the
association of these opposing changes may have helped to
conceal any specific effect. Many patients had statin therapy
initiated at the time of infarction; regression in angiographic
stenosis, which would be expected with such therapy over
this time period (14), is far less than we observed. Only
angiographically smooth nonculprit lesions were included in
this study, so thrombus dissipation is unlikely to be respon-
sible. Furthermore, if the nonculprit lesions had unidenti-
fied plaque rupture and thrombus, available evidence from
angiographic follow-up of unstable lesions suggests they
would get more rather than less stenotic (15).
Thus, vasoconstriction would seem the most likely cause
of nonculprit lesion exaggeration. Circulating catechol-
amine levels are increased during AMI and significantly
enhance microvascular coronary resistance reducing non-
IRA flow (8,9). In an attempt to evaluate whether variation
in sympathetic tone could be responsible, we correlated
changes in heart rate and blood pressure with changes in
stenosis severity and found no significant association. How-
ever, RCA-related infarction may reduce heart rate and
blood pressure through conduction system and right ven-
tricular ischemia, respectively. In patients with non-RCA
AMI, diastolic blood pressure was significantly higher and
there was a trend toward higher systolic blood pressure,
Table 2. Lesion Characteristics and Hemodynamics
Infarct Angiogram Noninfarct Angiogram p Value
Minimal luminal diameter (mm) 1.53 (0.51) 1.78 (0.65)  0.001
Stenosis—nonculprit (%) 49.3 (14.5) 40.4 (16.6)  0.0001
Reference diameter (mm) 3.1 (0.8) 3.0 (0.8) 0.3
Heart rate (beats/min)
All patients (n  48) 73 (15.0) 72 (11.0) 0.8
RCA IRA (n  11) 70 (7.8) 71 (10.4) 0.28
Non-RCA IRA (n  37) 72 (15.1) 71 (10.7) 0.79
Systolic blood pressure (mm Hg)
All patients (n  48) 130 (28.2) 123 (23.5) 0.1
RCA IRA (n  11) 128 (31.5) 124 (15.2) 0.75
Non-RCA IRA (n  37) 130 (27.1) 123 (23.9) 0.15
Diastolic blood pressure (mm Hg)
All patients (n  48) 74 (16.9) 66 (10.6)  0.05
RCA IRA (n  11) 69 (13.2) 70 (9.5) 0.88
Non-RCA IRA (n  37) 73 (17.0) 66 (10.4)  0.01
Data are mean (SD).
IRA  infarct-related artery; RCA  right coronary artery.
Table 3. Medications at Time of Coronary Angiogram
Medication
n  48
Infarct
Angiogram
Noninfarct
Angiogram p Value
Aspirin 47 (98%) 48 (100%) 0.3
Nitrate 44 (92%) 20 (42%)  0.01
Heparin 47 (98%) 10 (21%)  0.01
Beta-blocker 14 (29%) 34 (71%)  0.01
Angiotensin-converting
enzyme inhibitor
14 (29%) 45 (94%)  0.01
Statin 11 (23%) 40 (83%)  0.01
Calcium antagonist 3 (6%) 3 (6%) ns
Clopidogrel 1 (2%) 23 (48%)  0.01
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providing some evidence of increased sympathetic drive.
However, even in the non-RCA group these changes in
hemodynamics between studies did not correlate with
changes in nonculprit stenosis. Bioactivity of several other
important coronary vasoconstrictors, including serotonin,
endothelin, angiotensin, and thromboxane, is also increased
during myocardial infarction (16,17), whereas oxidant stress
reduces the vasodilatory effects of nitric oxide, adenosine,
and prostacyclin (18,19). However, as this was a retrospec-
tive study, we could not obtain direct evidence of the relative
contribution of each of these biochemical abnormalities. An
accurate assessment of the relative importance of specific
vasoconstrictors would require further study with sequential
administration of selectively targeted intracoronary vasodi-
lators and may enable exclusion of nonculprit coronary
stenosis reversibility.
Study limitations. This study has several limitations. First,
it is a retrospective study where the study group may be
subject to selection bias; those patients who were subject to
repeat angiography may be not totally representative of all
patients undergoing infarct PCI. The most obvious factor
that reduced the chance of repeat angiography was whether
the patient was having primary or rescue PCI. This most
likely relates to understandable differences in practice in
centers with and those without angiographic facilities.
Demographics were very similar in the whole group and the
PP group (and thus by subtraction the RP group), suggest-
ing that the findings in PP are likely to be similar in those
RP patients who did not have repeat angiography. Second,
although off-line QCA analysis methods were standard,
acquisition was not uniform. In our lab most angulation and
tower heights are standard with a constant source to patient
length and minimal tower height for each view, creating
some reproducibility: only 18 of a possible 66 patients were
excluded because of variation in views. Last, because of the
almost uniform therapy with nitrates at AMI and
angiotensin-converting enzyme inhibitors and statins at
follow-up, the ability of multiple logistic regression to
discern the importance of these therapy differences in
reduced nonculprit lesion stenosis is limited.
Clinical implications. Nonculprit PCI at the time of AMI
may be associated with increased risk of acute closure and
restenosis due to high circulating levels of procoagulants and
growth factors respectively. However, evidence has lately
been accumulating in favor of nonculprit PCI. Recent
angiographic evidence suggests that plaque instability is a
multifocal process and that unstable lesions in the non-
infarct-related artery predispose to recurrent acute coronary
syndromes (11). Serologic evidence shows that markers of
arterial wall inflammation are often persistently elevated
after infarction and predict further acute coronary syn-
dromes (20). In addition, flow in nonculprit arteries is
significantly impaired at the time of infarction, and resto-
ration of normal flow in the non-IRA territory appears to
aid recovery of left ventricular function after myocardial
infarction (9). The only published data on this controversy
is a retrospective case-control study comparing multivessel
PCI at the time of infarction with a staged approach (21).
Immediate nonculprit PCI had a 96% success rate, a figure
that would seem to argue for immediate nonculprit PCI
rather than against it, but was associated with an excess of
death and stroke, despite matching for age and Killip class.
Randomized data would help clarify this apparent contra-
diction.
Amidst this confusion, our data would suggest that some
nonculprit interventions may be avoidable in such an un-
friendly and uncertain milieu. If vasoconstriction is the main
cause, it would be useful to develop a safe and effective
protocol to identify those patients in whom nonculprit PCI
is unnecessary to improve the risk-benefit ratio of immedi-
ate PCI, or to accurately identify those lesions that should
be revascularized when the dust has settled.
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